Research roundup

innovation: candle, tungsten bulb, two modern light bulbs
Debbie Rigby covers the latest research relevant to pharmacists Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder This study represents the first evaluation of the relative benefits of onabotulinumtoxinA compared with mirabegron in adults with idiopathic overactive bladder. An indirect comparison indicates that onabotulinumtoxinA may be superior to mirabegron in improving symptoms of urinary

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Five key medicines priorities
Next NAPSA launches alumni network